SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Laboratory Corp of America Holdings – ‘8-K’ for 3/19/21

On:  Friday, 3/19/21, at 7:10am ET   ·   For:  3/19/21   ·   Accession #:  920148-21-24   ·   File #:  1-11353

Previous ‘8-K’:  ‘8-K/A’ on 3/3/21 for 11/2/20   ·   Next:  ‘8-K’ on 3/26/21 for 3/25/21   ·   Latest:  ‘8-K’ on 5/14/21 for 5/12/21

Magnifying glass tilted right emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/19/21  Lab Corp of America Holdings      8-K:7,9     3/19/21   13:191K

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     25K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     13K 
 9: R1          Cover page Cover page                               HTML     47K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- lh-20210319_htm                     XML     24K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.CAL  XBRL Calculations -- lh-20210319_cal                 XML      7K 
 5: EX-101.DEF  XBRL Definitions -- lh-20210319_def                  XML      9K 
 6: EX-101.LAB  XBRL Labels -- lh-20210319_lab                       XML     69K 
 7: EX-101.PRE  XBRL Presentations -- lh-20210319_pre                XML     33K 
 3: EX-101.SCH  XBRL Schema -- lh-20210319                           XSD     12K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    18K 
13: ZIP         XBRL Zipped Folder -- 0000920148-21-000024-xbrl      Zip     15K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  lh-20210319  
 i March 19, 2021 i 0000920148 i false00009201482021-03-192021-03-1900009201482021-02-232021-02-23

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

FORM  i 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 i March 19, 2021
(Date of earliest event reported)
 i LABORATORY CORPORATION OF AMERICA HOLDINGS
(Exact Name of Registrant as Specified in its Charter)
 i Delaware  i 1-11353  i 13-3757370
(State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

 i 358 South Main Street 
 i Burlington, i North Carolina i 27215
(Address of principal executive offices)(Zip Code)
(Registrant’s telephone number including area code)  i 336- i 229-1127
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 i Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act.
Title of Each Class            Trading Symbol            Name of exchange on which registered
 i Common Stock , $0.10 par value         i LH                 i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).             
                                        Emerging growth company  i 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01Regulation FD Disclosure
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at KeyBanc Capital Markets' Life Sciences and MedTech Investor Forum on Wednesday, March 24 at 2:00 p.m. ET.
Item 9.01
Financial Statements and Exhibits.

ExhibitExhibit Name
Exhibit 99.1




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LABORATORY CORPORATION OF AMERICA HOLDINGS
Registrant

 By:/s/ SANDRA VAN DER VAART
  Sandra van der Vaart
  Executive Vice President, Chief Legal Officer and Corporate Secretary

 i March 19, 2021


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:3/19/21None on these Dates
 List all Filings 
Top
Filing Submission 0000920148-21-000024   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2021 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 14, 7:04:08.0am ET